SightfileU.S. market data from official filings

Companies › LMAT

LEMAITRE VASCULAR INC (LMAT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001158895 · EDGAR filings · Updated 2026-07-27

LEMAITRE VASCULAR INC (LMAT) has reported institutional ownership of 96.8%, with 339 institutional managers holding positions valued at $2.41B per the latest 13F reporting period.

Institutional ownership
96.8%
Institutional managers
339
Reported 13F value
$2.41B
Insider activity
164 trans.
−$43.9M net selling

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LEMAITRE VASCULAR INC has 339 institutional holders and institutional ownership of 96.8%.

Insider activity

Insiders reported 164 transactions (0 buys, 21 sells) across 10 reporting insiders, with a net reported value of −$43.9M.

Related companies

MINERALYS THERAPEUTICS INC (MLYS) · ENLIVEN THERAPEUTICS INC (ELVN) · VIKING THERAPEUTICS INC (VKTX) · BIOCRYST PHARMACEUTICALS INC (BCRX) · LIFESTANCE HEALTH GROUP INC (LFST) · SYNDAX PHARMACEUTICALS INC (SNDX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.